Invention Grant
- Patent Title: Azaindole derivatives as multi kinase inhibitors
- Patent Title (中): Azaindole衍生物作为多激酶抑制剂
-
Application No.: US14655609Application Date: 2013-12-30
-
Publication No.: US09550772B2Publication Date: 2017-01-24
- Inventor: Gwénaël Cheve , Bénédicte Dayde-Cazals , Bénédicte Fauvel , Cédric Bories , Abdelaziz Yasri
- Applicant: ORIBASE PHARMA
- Applicant Address: FR Montpellier
- Assignee: ORIBASE PHARMA
- Current Assignee: ORIBASE PHARMA
- Current Assignee Address: FR Montpellier
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: FR1262931 20121228
- International Application: PCT/EP2013/078139 WO 20131230
- International Announcement: WO2014/102377 WO 20140703
- Main IPC: C07D401/02
- IPC: C07D401/02 ; C07D401/10 ; A61K31/437 ; A61K31/4353 ; C07D471/04 ; G01N33/574
Abstract:
The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.
Public/Granted literature
- US20150353539A1 AZAINDOLE DERIVATIVES AS MULTI KINASE INHIBITORS Public/Granted day:2015-12-10
Information query
